Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/11/17 14:02 | 5/9/17 | KITE | Health | BioPrd | Biological Products, (No Diag | Nussbaum Ran | CA | D | P | 679 | 69.11 | 33 | 10 | 5 | I | 34 | 64 | 64 | 43 | -4 | -8 | -10 | -8 | 0 | |||||||
5/10/17 15:12 | 5/10/17 | KITE | Health | BioPrd | Biological Products, (No Diag | Jenkinson Paul L | CA | O | CFO | P | 250 | 72.59 | 33 | 3 | 49 | 10 | M | 28 | 57 | 69 | 36 | -8 | -9 | -12 | -14 | 4 | |||||
5/10/17 12:52 | 5/9/17 | KITE | Health | BioPrd | Biological Products, (No Diag | Ruchefsky Steven B | CA | D | P | 97 | 69.50 | 33 | 1 | 1 | 225 | D | 28 | 57 | 69 | 36 | -8 | -9 | -12 | -14 | 4 | ||||||
5/9/17 18:29 | 5/9/17 | KITE | Health | BioPrd | Biological Products, (No Diag | Bonderman David | CA | D | P | 3,447 | 68.94 | 33 | 50 | 2 | 2,410 | I | 27 | 59 | 77 | 33 | -9 | -11 | -14 | -13 | 4 | ||||||
5/9/17 15:37 | 5/9/17 | KITE | Health | BioPrd | Biological Products, (No Diag | Belldegrun Arie | CA | DO | CB,P,CEO | P | 1,166 | 68.57 | 33 | 17 | 1 | 3,283 | D | 27 | 59 | 77 | 33 | -9 | -11 | -14 | -13 | 2 | |||||
6/17/15 19:19 | 6/25/14 | KITE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | VP Clini | P.d | 68 | 17.00 | 33 | 4 | 328 | 5 | D | 8 | -7 | 10 | 11 | -5 | 1 | 3 | 6 | 26 | 8 | 8 | -11 | ||
6/17/15 19:17 | 6/25/14 | KITE | Health | BioPrd | Biological Products, (No Diag | Chang David D | CA | O | EVP,R,D, | P.d | 68 | 17.00 | 33 | 4 | 200 | 6 | D | 8 | -7 | 10 | 11 | -5 | 1 | 3 | 6 | 26 | 8 | 8 | -11 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |